Integrating our data with genetic and clinical data for human disease risk, our analyses suggest potential targets like G-CSF/CSF-3, CXCL9/MIG, and TNF-b for immune-related diseases including asthma, Crohn’s disease, and multiple sclerosis, warranting further exploration in clinical trials. This evidence concerns the gene CXCL9 and multiple sclerosis.